NO172342C - Fremgangsmaate for fremstilling av 2-(2-(4-((4-klorfenyl)-fenylmethyl)-1-piperazinyl)-ethoxy)-eddiksyre og dens dihydroklorid, og mellomprodukt for anvendelse ved fremgangsmaaten - Google Patents

Fremgangsmaate for fremstilling av 2-(2-(4-((4-klorfenyl)-fenylmethyl)-1-piperazinyl)-ethoxy)-eddiksyre og dens dihydroklorid, og mellomprodukt for anvendelse ved fremgangsmaaten

Info

Publication number
NO172342C
NO172342C NO894651A NO894651A NO172342C NO 172342 C NO172342 C NO 172342C NO 894651 A NO894651 A NO 894651A NO 894651 A NO894651 A NO 894651A NO 172342 C NO172342 C NO 172342C
Authority
NO
Norway
Prior art keywords
detic
chlorphenyl
phenylmethyl
dihydrochloride
piperazinyl
Prior art date
Application number
NO894651A
Other languages
English (en)
Norwegian (no)
Other versions
NO894651L (no
NO172342B (no
NO894651D0 (no
Inventor
Eric Cossement
Genevieve Motte
Guy Bodson
Jean Gobert
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO894651D0 publication Critical patent/NO894651D0/no
Publication of NO894651L publication Critical patent/NO894651L/no
Publication of NO172342B publication Critical patent/NO172342B/no
Publication of NO172342C publication Critical patent/NO172342C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO894651A 1988-11-23 1989-11-22 Fremgangsmaate for fremstilling av 2-(2-(4-((4-klorfenyl)-fenylmethyl)-1-piperazinyl)-ethoxy)-eddiksyre og dens dihydroklorid, og mellomprodukt for anvendelse ved fremgangsmaaten NO172342C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827391A GB8827391D0 (en) 1988-11-23 1988-11-23 Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride

Publications (4)

Publication Number Publication Date
NO894651D0 NO894651D0 (no) 1989-11-22
NO894651L NO894651L (no) 1990-05-25
NO172342B NO172342B (no) 1993-03-29
NO172342C true NO172342C (no) 1993-07-07

Family

ID=10647347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894651A NO172342C (no) 1988-11-23 1989-11-22 Fremgangsmaate for fremstilling av 2-(2-(4-((4-klorfenyl)-fenylmethyl)-1-piperazinyl)-ethoxy)-eddiksyre og dens dihydroklorid, og mellomprodukt for anvendelse ved fremgangsmaaten

Country Status (16)

Country Link
KR (1) KR970009728B1 (fr)
AT (1) AT398971B (fr)
CA (1) CA1317300C (fr)
CY (1) CY1671A (fr)
DK (1) DK174543B1 (fr)
ES (1) ES2021907A6 (fr)
FI (1) FI91862C (fr)
GB (2) GB8827391D0 (fr)
GR (1) GR1000553B (fr)
HK (1) HK95892A (fr)
HU (1) HU205094B (fr)
NO (1) NO172342C (fr)
PH (1) PH25982A (fr)
PL (1) PL161379B1 (fr)
PT (1) PT92364B (fr)
SG (1) SG89492G (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950412A3 (fr) * 1992-09-24 2001-05-16 Sepracor, Inc. Compositions pour traiter des affections allergiques à l'aide de (-) cétirizine
AU703690B2 (en) * 1992-09-24 1999-04-01 Sepracor, Inc. Methods for treating allergic disorders using optically pure (+)cetirizine
AU5136193A (en) * 1992-09-24 1994-04-12 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
AU7455798A (en) 1997-06-04 1998-12-21 Nippon Shoji Kaisha, Ltd. Process for producing piperazinesulfonamide derivatives and salts thereof
EP0919550A1 (fr) * 1997-11-26 1999-06-02 Ucb, S.A. Formes pseudopolymorphiques de l'acide 2-2-4-bis(4-fluorophényl)méthyl -1-pipérazinyl-éthoxy acétique dihydrochloride
IL124195A (en) * 1998-04-23 2000-08-31 Chemagis Ltd Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
GR990100135A (el) * 1999-04-22 2000-12-29 Genepharm �.�. Μεθοδος παρασκευης του 2-(2-[4-[4-χλωροφαινυλο)(φαινυλο)μεθυλο]πιπεραζινο]αιθοξυ) οξικου οξεος και του διυδροχλωρικου αλατος αυτου
JP2002249487A (ja) * 2001-02-22 2002-09-06 Sumitomo Chem Co Ltd 4−(tert−ブトキシカルボニル)ピペラジン誘導体、その光学活性な酸付加塩、それらの製造法、およびそれらを用いる光学活性な1−[(置換フェニル)フェニルメチル]ピペラジンの製造法。
US6977301B1 (en) 2001-05-29 2005-12-20 Ucb, S.A. Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US7199241B1 (en) 2001-05-29 2007-04-03 Ucb, S.A. Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
CN100378086C (zh) * 2003-01-23 2008-04-02 Ucb法奇姆股份有限公司 哌嗪衍生物和它们作为合成中间体的应用
KR100503443B1 (ko) 2004-02-02 2005-07-22 한림제약(주) 광학적으로 활성인 세티리진 또는 그의 염의 제조방법
EP1858866B1 (fr) * 2005-03-03 2009-06-10 Ucb Farchim, S.A. Sels de pyroglutamate et leur utilisation dans la résolution optique de produits intermédiaires pour la préparation de dextrocetirizine et levocetirizine
HU227325B1 (en) * 2005-12-08 2011-03-28 Egis Gyogyszergyar Nyrt Process for the production of an intermediate of (dextro- and levo)- cetirizine
US8049011B2 (en) 2007-03-12 2011-11-01 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of levocetirizine and intermediates thereof
SI22489A (sl) * 2007-03-12 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek za pripravo levocetirizina in njegovih intermediatov
WO2008152650A1 (fr) 2007-06-15 2008-12-18 Symed Labs Limited Procédé de préparation d'énantiomères lévogyres et dextrogyres sensiblement optiquement purs de cétirizine à l'aide de nouveaux intermédiaires
WO2009062036A2 (fr) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Procédés de préparation de lévocétirizine et de ses sels pharmaceutiquement acceptables
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
PL2062881T3 (pl) 2007-11-21 2011-07-29 Synthon Bv Sposób wytwarzania N-(difenylometylo)piperazyn
KR20110022635A (ko) 2008-06-02 2011-03-07 시플라 리미티드 레보세티리진의 합성방법 및 이에 사용하기 위한 중간체
EP2297122B1 (fr) * 2008-06-11 2014-05-21 KRKA, tovarna zdravil, d.d., Novo mesto Nouveau procédé pour la préparation de la lévocétirizine et de ses intermédiaires
KR100998067B1 (ko) 2008-09-08 2010-12-03 주식회사 삼오제약 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법
US20110172425A1 (en) 2008-09-17 2011-07-14 Calyx Chemicals And Pharmaceuticals Pvt. Ltd. Novel water based process for the preparation of substituted diphenylmethyl piperazines
WO2010107404A1 (fr) 2009-03-16 2010-09-23 Mahmut Bilgic Combinaisons pharmaceutiques stables
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009398A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Fiziksel özellikleri geliştirilmiş tablet formülasyonları
WO2012101475A1 (fr) 2011-01-27 2012-08-02 Jubilant Life Sciences Limited Procédé de préparation amélioré d'antihistaminiques faisant appel à un nouvel intermédiaire carbamate
CN103044355A (zh) * 2011-10-13 2013-04-17 湖南九典制药有限公司 合成左西替利嗪的关键中间体及其制备方法
KR101418404B1 (ko) 2012-01-06 2014-07-10 한미약품 주식회사 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제
KR102226833B1 (ko) 2013-06-28 2021-03-12 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성이 개선된 복합 과립 제형
CN104045607B (zh) * 2014-05-21 2016-04-13 丽珠医药集团股份有限公司 一种盐酸西替利嗪的纯化方法
CN105924409B (zh) * 2016-05-12 2019-01-08 浙江永宁药业股份有限公司 一种(r)-1-((2-氯苯基)-(苯基)-甲基)-哌嗪的拆分方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.

Also Published As

Publication number Publication date
HU896131D0 (en) 1990-02-28
PL161379B1 (pl) 1993-06-30
PT92364B (pt) 1995-07-18
ES2021907A6 (es) 1991-11-16
NO894651L (no) 1990-05-25
SG89492G (en) 1992-12-04
CY1671A (en) 1993-05-14
DK174543B1 (da) 2003-05-19
KR970009728B1 (ko) 1997-06-17
NO172342B (no) 1993-03-29
GB8827391D0 (en) 1988-12-29
DK586789D0 (da) 1989-11-22
GB2225321B (en) 1992-04-08
FI91862C (fi) 1994-08-25
KR900007825A (ko) 1990-06-02
DK586789A (da) 1990-05-24
AT398971B (de) 1995-02-27
HU205094B (en) 1992-03-30
PT92364A (pt) 1990-05-31
NO894651D0 (no) 1989-11-22
FI91862B (fi) 1994-05-13
CA1317300C (fr) 1993-05-04
GB2225321A (en) 1990-05-30
GB8926243D0 (en) 1990-01-10
PH25982A (en) 1992-01-13
FI895564A0 (fi) 1989-11-22
ATA266589A (de) 1994-07-15
HK95892A (en) 1992-12-11
GR1000553B (el) 1992-08-26
HUT53627A (en) 1990-11-28
GR890100770A (en) 1990-12-31

Similar Documents

Publication Publication Date Title
NO172342C (no) Fremgangsmaate for fremstilling av 2-(2-(4-((4-klorfenyl)-fenylmethyl)-1-piperazinyl)-ethoxy)-eddiksyre og dens dihydroklorid, og mellomprodukt for anvendelse ved fremgangsmaaten
NO894650D0 (no) Fremgangsmaate for fremstilling av 2-(2-(4-((4-klorfenyl)-fenylmethyl)-piperazinyl)-ethoxy)-eddiksyre og dens dihydroklorid.
AR240698A1 (es) Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
PL294704A1 (en) Method of obtaining 4-(2-(2-hydroxy-2-phenylethylamine)ethoxy) phenyloacetic acid and its bioprecursor substances
ZA828549B (en) 2-(4-(4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl)pyrimidines
NO933093D0 (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid
SG29687G (en) 2-(4-((4, 4-dialkyl-2, 6-piperidinedion-1-yl) butyl)-1-piperazinyl) pyridines
PT70967A (en) Process for the preparation of 2,5-bis(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamide
DE3874206D1 (de) 2-(3-4-dihydroxyphenyl)-aethylamine, ihre herstellung und ihre verwendung als arzneimittel.
MX9205186A (es) Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona
NO794279L (no) Fremgangsmaate til fremstilling av 6,7-dimetoksy-4-amino-2-(4-(furoyl)-1-piperazinyl)-kinazolin-hydroklorid med blodtrykksenkende virkning
NO870891L (no) FremgangsmŸte ved fremstilling av 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.
DK150477C (da) Analogifremgangsmaade til fremstilling af 4-(4-(naphthalenyloxy)-1-piperidinyl)-1-phenyl-1-butanonderivater og mellemprodukter til brug ved fremgangsmaaden
HU9500453D0 (en) 1-[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine derivatives, process for preparing them and their medical use
PL287224A1 (en) Method of obtaining 2-(2-(4-(/4-chlorophenyl/phenylmethyl)-1-piperazinyl) ethoxy) acetic acid and its dihydrohloride
DE69128845D1 (de) 4-[3-(4-Oxothiazoldinyl)]butynylamine, Verfahren zu deren Herstellung und ihre Verwendung als Medikament
DE3165040D1 (en) 2-(2-amino-thiazol-4-yl)-n-(imidazolidin and perhydro-1,3-diazin-2-on-1-yl)-2-iminoacetylcephalosporins of the syn-form, and process for their preparation
MX9205608A (es) Procedimiento para la preparacion de: cis-1-aceti -4-(4-((2-(2-,4-diclorofenil)-2-(1h-imidazol-1-il-metil)-1,3-dioxolan-4-il)-metoxi)fenil)piperazina
NO914376D0 (no) Fremgangsmaate for fremstilling av 1-(2-((5-dimetylaminometyl-2-furyl)-metyltio)-etyl)-amino-1-metylamino-2-nitroetylen

Legal Events

Date Code Title Description
MK1K Patent expired